Literature DB >> 10691624

Isolation and identification of stilbenes in two varieties of Polygonum cuspidatum.

B C Vastano1, Y Chen, N Zhu, C T Ho, Z Zhou, R T Rosen.   

Abstract

The roots of two varieties of Polygonum cuspidatum (Hu Zhang and Mexican Bamboo) were analyzed for resveratrol and analogues. The roots of each variety were dried and ground into a powder. The powdered roots were then extracted with methanol and ethyl acetate. The ethyl acetate fraction of the Mexican Bamboo was then subjected to fractionation and purification using silica gel column chromatography and semipreparative HPLC. In addition to resveratrol (3,5,4'-trihydroxystilbene), three stilbene glucosides were identified by (1)H NMR, (13)C NMR, and MS. The stilbene glucosides were shown to be a piceatannol glucoside (3,5,3', 4'-tetrahydroxystilbene 4'-O-beta-D-glucopyranoside), resveratroloside (3,5,4'-trihydroxystilbene 4'-O-beta-D-glucopyranoside), and piceid (3,5,4'-trihydroxystilbene 3-O-beta-D-glucopyranoside). The levels of the piceatannol glucoside and piceid were twice as high in the Mexican Bamboo as compared to the Hu Zhang.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10691624     DOI: 10.1021/jf9909196

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  33 in total

Review 1.  Astonishing diversity of natural surfactants: 5. Biologically active glycosides of aromatic metabolites.

Authors:  Valery M Dembitsky
Journal:  Lipids       Date:  2005-09       Impact factor: 1.880

2.  Escherichia coli modular coculture system for resveratrol glucosides production.

Authors:  Nguyen Huy Thuan; Nguyen Thanh Trung; Nguyen Xuan Cuong; Duong Van Cuong; Dong Van Quyen; Sailesh Malla
Journal:  World J Microbiol Biotechnol       Date:  2018-05-23       Impact factor: 3.312

3.  Dose-dependency of resveratrol in providing health benefits.

Authors:  Subhendu Mukherjee; Jocelyn I Dudley; Dipak K Das
Journal:  Dose Response       Date:  2010-03-18       Impact factor: 2.658

4.  Resveratrol content and antioxidant properties of underutilized fruits.

Authors:  Akshatha Shrikanta; Anbarasu Kumar; Vijayalakshmi Govindaswamy
Journal:  J Food Sci Technol       Date:  2013-05-04       Impact factor: 2.701

5.  Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study.

Authors:  H-H Sherry Chow; Linda L Garland; Chiu-Hsieh Hsu; Donna R Vining; Wade M Chew; Jessica A Miller; Marjorie Perloff; James A Crowell; David S Alberts
Journal:  Cancer Prev Res (Phila)       Date:  2010-08-17

Review 6.  Targeting cancer stem cells and signaling pathways by phytochemicals: Novel approach for breast cancer therapy.

Authors:  Prasad R Dandawate; Dharmalingam Subramaniam; Roy A Jensen; Shrikant Anant
Journal:  Semin Cancer Biol       Date:  2016-09-05       Impact factor: 15.707

Review 7.  Oxidative stress and skin cancer: an overview.

Authors:  R T Narendhirakannan; M Angeline Christie Hannah
Journal:  Indian J Clin Biochem       Date:  2012-11-23

8.  Comparative toxicokinetics of Trans-resveratrol and its major metabolites in Harlan Sprague Dawley rats and B6C3F1/N mice following oral and intravenous administration.

Authors:  Esra Mutlu; Seth T Gibbs; Natalie South; Jessica Pierfelice; Brian Burback; Dori Germolec; Suramya Waidyanatha
Journal:  Toxicol Appl Pharmacol       Date:  2020-03-20       Impact factor: 4.219

9.  Resveratrol (3,5,4'-trihydroxystilbene) and its properties in oral diseases.

Authors:  Donatella Perrone; Maria Pia Fuggetta; Fatima Ardito; Andrea Cottarelli; Anna De Filippis; Giampietro Ravagnan; Salvatore De Maria; Lorenzo Lo Muzio
Journal:  Exp Ther Med       Date:  2017-05-18       Impact factor: 2.447

10.  Resveratrol Protects Purkinje Neurons and Restores Muscle Activity in Rat Model of Cerebellar Ataxia.

Authors:  Zeynab Ghorbani; Reza Mastery Farahani; Abbas Aliaghaei; Fariba Khodagholi; Gholam Houssein Meftahi; Samira Danyali; Mohammad Amin Abdollahifar; Mahtab Daftari; Mahdi Eskandarian Boroujeni; Yousef Sadeghi
Journal:  J Mol Neurosci       Date:  2018-05-01       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.